Skip to main content
. 2023 Feb 14;15(4):1219. doi: 10.3390/cancers15041219
ALCL anaplastic large cell lymphoma;
ALL acute lymphocytic leukemia
AML acute myeloid leukemia
AMP amplification
APL acute promyelocytic leukemia
ATLL adult T-cell leukemia lymphoma
B-ALL B-cell acute lymphocytic leukemia
B-NHL B-cell non-Hodgkin lymphoma
BRD bromodomain
CLL chronic lymphocytic leukemia
CML chronic myeloid leukemia
CNA copy number alteration
CRD1 cell cycle regulatory domain 1
CREBBP CREB-binding protein
DLBCL diffuse large B-cell lymphoma
EP300 E1A binding protein p300
eRNA enhancer RNA
ESC embryonic stem cell
FL follicular lymphoma
GC germinal center
HAT histone acetyltransferase
HATs histone acetyltransferase
HDACs histone deacetylases
HDACis histone deacetylase inhibitors
HL Hodgkin lymphoma
HOMDEL homozygous deletion
HSCs hematopoietic stem cells
HSPCs hematopoietic stem and progenitor cells
IBiD interferon-binding domain
IMiDs immunomodulatory drugs
KIX kinase-inducible domain of CREB interacting domain
LSTFL limited-stage typical follicular lymphoma
MDS myelodysplastic syndrome
MHC class II major histocompatibility complex class II
MM multiple myeloma
NLS nuclear location signal
NKG2D natural-killer group 2 member D
NRID nuclear receptor interaction domain
PHD plant homeodomain
PTCL peripheral T-cell lymphoma
RING really interesting new gene
T-ALL T-cell acute lymphocytic leukemia
TAZ1 transcriptional-adaptor zinc-finger domain 1
TAZ2 transcriptional-adaptor zinc-finger domain 2
Tregs T regulatory cells; ZZ: ZZ-type zinc finger.